Answers are grounded in this paper and cite their sources.
This study is devoted to developing amphiphilic, biodegradable, Y‐shaped block polymers, which can self‐assemble to form nanoparticles, as a glucose‐sensitive drug carrier. Y‐shaped poly(ethylene glycol)‐ block ‐[poly(lactic acid)‐ block ‐poly (2‐phenylborate esters‐1,3‐dioxane‐5‐methyl) methylacrylate)] 2 (MPEG‐(PLA‐ block ‐PPBDMMA) 2 ) polymers are constructed via a combination of ring‐opening polymerization (ROP) and atom transfer radical polymerization (ATRP) with MPEG‐(OH) 2 , having double initiation endings, as starting material. These Y‐shaped block polymers can disperse in an aqueous medium and self‐assemble into micellar aggregates with a spherical core–shell structure. Dynamic laser scattering (DLS), zeta potential measurements, and transmission electron microscopy (TEM) show the solution properties of these polymeric micelles with or without insulin loading. Compared with MPEG‐PLA‐ block ‐PPBDMMA linear polymer, in vitro insulin release at different glucose concentrations, revealed by the fluorescence technique, shows that the studied Y‐shaped polymers have intelligent glucose‐concentration‐dependent manner of insulin release at pH 7.4 and 37 °C. The bulk swelling phenomenon of the polymeric micelles formed from the Y‐shaped polymers is detected by DLS in the process of their glucose‐responsiveness. Such a Y‐shaped glucose‐responsive polymer is a promising candidate that holds great potential in the treatment of diabetes.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: